Brief: Procept Biorobotics Q4 Basic EPS USD -0.54
27/02/2024 21:02
Feb 27 (Reuters) - Procept Biorobotics Q4 net income USD -27.504 million. * Q4 adjusted EBITDA USD -23.284 million * Q4 revenue USD 43.581 million vs. IBES estimate USD 42.1 million * Q4 gross profit USD 21.255 million * Q4 operating income USD -29.557 million * outlook FY gross margin 57-59% * outlook FY revenue USD 210 million * outlook FY adjusted EBITDA USD -73 million
Recent news on PROCEPT BioRobotics
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Procept Biorobotics Corporation Enters Third Amendment To Loan And Security Agreement With Cibc